These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22047505)

  • 21. National survey of physicians' perspectives on pharmacogenetic testing in solid organ transplantation.
    Deininger KM; Tsunoda SM; Hirsch JD; Anderson H; Lee YM; McIlvennan CK; Page RL; Tran JN; Aquilante CL
    Clin Transplant; 2020 Oct; 34(10):e14037. PubMed ID: 32654213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenetic Testing: The Ethics of Implementing in Clinical Practice for Chronic Pain Patients.
    Fredrikson KM; Fasolino T
    J Pain Palliat Care Pharmacother; 2020 Jun; 34(2):69-76. PubMed ID: 31909692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.
    Haga SB; LaPointe NM; Cho A; Reed SD; Mills R; Moaddeb J; Ginsburg GS
    Pharmacogenomics; 2014 Sep; 15(13):1677-86. PubMed ID: 25410893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 'Information is information': a public perspective on incidental findings in clinical and research genome-based testing.
    Daack-Hirsch S; Driessnack M; Hanish A; Johnson VA; Shah LL; Simon CM; Williams JK
    Clin Genet; 2013 Jul; 84(1):11-8. PubMed ID: 23590238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Utilization of Pharmacogenetics in Psychiatry - Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry.
    Brown L; Eum S; Haga SB; Strawn JR; Zierhut H
    Pharmacopsychiatry; 2020 Jul; 53(4):162-173. PubMed ID: 31509860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients.
    Frigon MP; Blackburn MÈ; Dubois-Bouchard C; Gagnon AL; Tardif S; Tremblay K
    Pharmacogenomics; 2019 Jun; 20(8):589-598. PubMed ID: 31190623
    [No Abstract]   [Full Text] [Related]  

  • 27. Perplexed by PGx? Exploring the impact of pharmacogenomic results on medical management, disclosures and patient behavior.
    Waldman L; Shuman C; Cohn I; Kaiser A; Chitayat D; Wasim S; Hazell A
    Pharmacogenomics; 2019 Apr; 20(5):319-329. PubMed ID: 30983503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the readiness of physicians for pharmacogenomics testing: an empirical assessment.
    Amara N; Blouin-Bougie J; Bouthillier D; Simard J
    Pharmacogenomics J; 2018 Apr; 18(2):308-318. PubMed ID: 28607504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.
    Hess GP; Fonseca E; Scott R; Fagerness J
    Genet Res (Camb); 2015 Jun; 97():e13. PubMed ID: 26030725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporation of pharmacogenetic testing into medication therapy management.
    Haga SB; Moaddeb J; Mills R; Patel M; Kraus W; Allen LaPointe NM
    Pharmacogenomics; 2015 Nov; 16(17):1931-41. PubMed ID: 26555559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilizing a user-centered approach to develop and assess pharmacogenomic clinical decision support for thiopurine methyltransferase.
    Nguyen KA; Patel H; Haggstrom DA; Zillich AJ; Imperiale TF; Russ AL
    BMC Med Inform Decis Mak; 2019 Oct; 19(1):194. PubMed ID: 31623616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic Testing.
    Haga SB; Kantor A
    Health Aff (Millwood); 2018 May; 37(5):717-723. PubMed ID: 29733708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenomic testing: knowing more, doing better.
    Lunshof JE; Gurwitz D
    Clin Pharmacol Ther; 2012 Mar; 91(3):387-9. PubMed ID: 22343816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges to integrating pharmacogenetic testing into medication therapy management.
    Haga SB; Allen LaPointe NM; Moaddeb J
    J Manag Care Spec Pharm; 2015 Apr; 21(4):346-52. PubMed ID: 25803768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perception of personalized medicine, pharmacogenomics, and genetic testing among undergraduates in Hong Kong.
    Cheung NYC; Fung JLF; Ng YNC; Wong WHS; Chung CCY; Mak CCY; Chung BHY
    Hum Genomics; 2021 Aug; 15(1):54. PubMed ID: 34407885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetic testing: not as simple as it seems.
    Haga SB; Burke W
    Genet Med; 2008 Jun; 10(6):391-5. PubMed ID: 18496219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient characteristics, experiences and perceived value of pharmacogenetic testing from a single testing laboratory.
    Haga SB; Liu Y
    Pharmacogenomics; 2019 Jun; 20(8):581-587. PubMed ID: 31190624
    [No Abstract]   [Full Text] [Related]  

  • 38. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials.
    Fabbri C; Zohar J; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():36-44. PubMed ID: 29777729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives of Pediatric Providers Regarding Clinical Use of Pharmacogenetics.
    Avello K; Bell M; Stein Q; Bares V; Landsverk M; Salyakina D; McCafferty-Fernandez J; Kingsmore S; Bedrick A; Bhojwani D; Hoyme HE
    S D Med; 2021 Jul; 74(7):294-301. PubMed ID: 34449988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.